Palatin Technologies
PTN
$0.31
Share price
10.04%
Change (1 day)
-43.64%
Change (1 year)
Earnings for Palatin Technologies (PTN)
Earnings in 2022 (TTM): -$0.04 B
According to Palatin Technologies's latest financial reports the company's current earnings (TTM) are -$0.04 B. In 2021 the company made an earning of -$0.04 B a decrease over its 2020 earnings that were of -$0.03 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Palatin Technologies from 2001 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | -$0.04 B | 5.36% |
| 2021 | -$0.04 B | 33.25% |
| 2020 | -$0.03 B | -172.11% |
| 2019 | $0.03 B | 2352.33% |
| 2018 | $1.5 M | -94.13% |
| 2017 | $0.02 B | -154.92% |
| 2016 | -$0.05 B | 3.67% |
| 2015 | -$0.05 B | 878% |
| 2014 | -$4.61 M | -72.64% |
| 2013 | -$0.02 B | -33.11% |
| 2012 | -$0.03 B | |
| 2003 | -$0.03 B | 29.93% |
| 2002 | -$0.02 B | 37.9% |
| 2001 | -$0.02 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $21.33 B | -60,310.61% | 🇺🇸 USA |
 Astrazeneca AZN | -$0.02 B | -68.96% | 🇬🇧 UK |
 Neurocrine Biosciences
NBIX | $0.11 B | -431.82% | 🇺🇸 USA |
 MediciNova MNOV | -$0.02 B | -62.12% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $0.03 B | -201.51% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | -$0.12 B | 231.97% | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | -$0.07 B | 86.09% | 🇺🇸 USA |
 GlycoMimetics
GLYC | -$0.07 B | 80.10% | 🇺🇸 USA |
 Ardelyx ARDX | -$0.15 B | 320.22% | 🇺🇸 USA |